The worldwide Scar Treatment market measurement is anticipated to achieve USD 56.3 billion by 2030 and is anticipated to increase at a CAGR of 15.1% from 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38460
Growth Factors
Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics. Acne scars are one of the most common concerns. Rise in the number of road accidents also results in several marks, which many a time require surgical assistance.
Hence, patients who have undergone such surgeries are generally provided with topical products for scar reduction. Cosmetic surgeries with laser instruments are also being undertaken for treating severe marks from road accidents. To remove such marks, plastic surgeries or resurfacing laser therapies are being preferred. Technologically advanced scar removal products minimize pain and facilitate a hassle-free healing process. For instance, UltraPulse by Lumenis uses CO2 laser for the treatment of acne scars reduces the risk of pain during the treatment process.
Report Highlights
Topical products held the largest share of 68.0% in 2020. The availability of topical gels, creams, and silicone sheets as Over-the-Counter (OTC) products enables individuals to utilize them as a treatment for scars. Laser products are also used extensively as they provide a non-invasive and painless alternative for the treatment of scars with minimal discomfort.
Atrophic scars held the largest share of 46.4% in 2020 due to the rising prevalence of acne scars. These scars are usually treated with topical creams and gels. Hypertrophic and keloid scars are anticipated to witness significant growth over the forecast period owing to their frequent occurrence among people with wound injuries.
The hospitals segment dominated the market with a share of 53.0% in 2020 owing to the usage of sophisticated infrastructure and the presence of technologically advanced products in these settings for scar treatment. The retail pharmacies/e-commerce segment is projected to witness the fastest growth over the forecast period due to the rapid growth of online websites and easy access to scar treatment products on these websites. The outbreak of COVID-19 is also expected to boost the growth of the segment.
North America dominated the market with a revenue share of 45.2% in 2020 owing to the high aesthetic consciousness among people and the rapid adoption of advanced products. In addition, advanced laser instruments for scar treatment are in high demand in the U.S.The U.S. held the largest share in the North American market in 2020. According to the American Burn Association (ABA), there are 486,000 burn cases annually.
Asia Pacific is expected to exhibit the highest CAGR of 21.4% over the forecast period due to the high incidence of road accidents in countries such as India. Key countries in the Asia Pacific market are India and China.
Key Players
- Smith & Nephew PLC
- Lumenis
- Merz Pharmaceuticals, LLC
- Sonoma Pharmaceuticals, Inc.
- Cynosure
- CCA Industries, Inc.
- Newmedical Technology Inc.
- Mölnlycke Health Care AB
- Suneva Medical
| Report Coverage | Details |
| Market Size | US$ 56.3 billion by 2030 |
| Growth Rate | CAGR of 15.1% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Scar type, End-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Smith & Nephew PLC; Lumenis; Merz Pharmaceuticals, LLC; Sonoma Pharmaceuticals, Inc.; Cynosure; CCA Industries, Inc.; Newmedical Technology Inc.; Mölnlycke Health Care AB; Suneva Medical |
Market Segmentation
- Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- CO2 Laser
- Pulse-dyed Laser
- Others
- Injectables
- Others
- Topical Products
- Scar Type
- Atrophic Scars
- Hypertrophic and Keloid Scars
- Contracture Scars
- Stretch Marks
- End-use
- Hospitals
- Clinics
- Retail Pharmacies/ E-commerce
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- China
- Japan
- India
- Singapore
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38460
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Scar Treatment Market, By Product
7.1. Scar Treatment Market, by Product, 2021-2030
7.1.1. Topical Products
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Laser Products
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Injectables
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Scar Treatment Market, By Scar Type
8.1. Scar Treatment Market, by Scar Type, 2021-2030
8.1.1. Atrophic Scars
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Hypertrophic and Keloid Scars
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Contracture Scars
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Stretch Marks
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Scar Treatment Market, By End-use
9.1. Scar Treatment Market, by End-use, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Retail Pharmacies/ E-commerce
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Scar Treatment Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.1.3. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.2.3. Market Revenue and Forecast, by End-use (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.3.3. Market Revenue and Forecast, by End-use (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.4.3. Market Revenue and Forecast, by End-use (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.5.3. Market Revenue and Forecast, by End-use (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Scar Type (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Smith & Nephew PLC
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Lumenis
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Merz Pharmaceuticals, LLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Sonoma Pharmaceuticals, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cynosure
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. CCA Industries, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Newmedical Technology Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Mölnlycke Health Care AB
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Suneva Medical
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38460
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
